当前位置: 首页 > 期刊 > 《中华现代临床医学杂志》 > 2005年第18期
编号:10740982
大黄在危重病患者中的应用价值探讨
http://www.100md.com 《中华现代临床医学杂志》 2005年第18期
应用价值,,大黄;危重病;应用价值,1资料与分析,2结果,3讨论,【参考文献】
     【摘要】 目的 观察大黄在危重病患者中的应用价值。方法 选择87例危重病患者,入选条件:(1)入院当天即行气管插管或气管切开,并机械通气;(2)入院当天已出现急性胃黏膜出血。随机分为治疗组(46例)和对照组(41例),其中治疗组给予生大黄粉,疗程10天,对照组给予法莫替丁,疗程10天,观察两组对胃黏膜出血的止血效果,并比较两组患者呼吸机相关肺炎(ventilator associated pneumonia,VAP)的发生率。结果 治疗组和对照组间止血效果差异无显著性(P>005),而VAP的发生率差异有非常显著性(P<001)。结论 大黄能有效控制危重病患者的急性胃黏膜病变,同时可减少VAP的发生。

    【关键词】 大黄;危重病;应用价值

    【Abstract】 Objective To review the applied value of dahuang on critical patients.Methods Selected 87 critically ill cases who:(1)were given for endotracheal intubation or tracheostomy and mechanical ventilation;(2)had happened acute gastric mucosa hemorrhage.All cases were divided into observation group(46 cases)and comparison group(41 cases).The observation groups were provided with dahuang for 10 days and the comparison groups were provided with Famotidine for over 10 days.Reviewing the effect of two groups on acute gastric mucosa hemorrhage and comparing the happening rate of Ventilator Associated Pneumonia(VAP).Results There was no obvious difference in effect of bleeding control between two groups(P>0.05) ......

您现在查看是摘要页,全文长 5301 字符